Assoc. Prof. Kezban Nur Pilancı, MD
Timeline
Career milestones.
Scientific work
Selected peer-reviewed publications.
-
2015Diagn Interv Radiol«The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer»· co-author · 112 citations
-
2017Saudi Med J«Hormone receptor status and survival of medullary breast cancer patients: A Turkish cohort»· co-author · 23 citations
-
2021Cancer Chemother Pharmacol«Efficacy and safety of trastuzumab emtansine in HER2 positive metastatic breast cancer: real-world experience»· co-author · 16 citations
-
2014Asian Pac J Cancer Prev«Can megestrol acetate induce thrombosis in advanced oncology patients receiving chemotherapy»· co-author · 16 citations
-
2018J Breast Cancer«Prognostic significance of adjuvant chemotherapy induced amenorrhea in luminal A and B subtypes»· co-author · 7 citations
-
2023Curr Med Res Opin«Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey»· co-author · 7 citations
Where they practise
Direct contract with BergemHealth at every listed clinic.
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.